Neonatal intensive care unit phthalate exposure and preterm infant neurobehavioral performance

Annemarie Stroustrup, Jennifer B Bragg, Syam S Andra, Paul C Curtin, Emily A Spear, Denise B Sison, Allan C Just, Manish Arora, Chris Gennings, Annemarie Stroustrup, Jennifer B Bragg, Syam S Andra, Paul C Curtin, Emily A Spear, Denise B Sison, Allan C Just, Manish Arora, Chris Gennings

Abstract

Every year in the United States, more than 300,000 infants are admitted to neonatal intensive care units (NICU) where they are exposed to a chemical-intensive hospital environment during a developmentally vulnerable period. The neurodevelopmental impact of environmental exposure to phthalates during the NICU stay is unknown. As phthalate exposure during the third trimester developmental window has been implicated in neurobehavioral deficits in term-born children that are strikingly similar to a phenotype of neurobehavioral morbidity common among children born premature, the role of early-life phthalate exposure on the neurodevelopmental trajectory of premature infants may be clinically important. In this study, premature newborns with birth weight <1500g were recruited to participate in a prospective environmental health cohort study, NICU-HEALTH (Hospital Exposures and Long-Term Health), part of the DINE (Developmental Impact of NICU Exposures) cohort of the ECHO (Environmental influences on Child Health Outcomes) program. Seventy-six percent of eligible infants enrolled in the study. Sixty-four of 81 infants survived and are included in this analysis. 164 urine specimens were analyzed for phthalate metabolites using high-performance liquid chromatography/tandem mass spectrometry. The NICU Network Neurobehavioral Scale (NNNS) was performed prior to NICU discharge. Linear and weighted quantile sum regression quantified associations between phthalate biomarkers and NNNS performance, and between phthalate biomarkers and intensity of medical intervention. The sum of di(2-ethylhexyl) phthalate metabolites (∑DEHP) was associated with improved performance on the Attention and Regulation scales. Specific mixtures of phthalate biomarkers were also associated with improved NNNS performance. More intense medical intervention was associated with higher ∑DEHP exposure. NICU-based exposure to phthalates mixtures was associated with improved attention and social response. This suggests that the impact of phthalate exposure on neurodevelopment may follow a non-linear trajectory, perhaps accelerating the development of certain neural networks. The long-term neurodevelopmental impact of NICU-based phthalate exposure needs to be evaluated.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. ∑DEHP metabolites by medical equipment…
Fig 1. ∑DEHP metabolites by medical equipment exposure group.
Molar ∑DEHP metabolites represented in ng/mL using the molecular weight of MEHP for conversion. Twenty-fifth percentile, median, and 75th percentile values in ng/mL are indicated for each medical equipment exposure group. Groups 1–3 are as defined in the Methods section, with group 1 representing the lowest exposure to medical equipment and group 3 representing the highest acuity, highest intensity equipment exposure.

References

    1. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412–7. doi: .
    1. Harrison W, Goodman D. Epidemiologic Trends in Neonatal Intensive Care, 2007–2012. JAMA Pediatr. 2015;169(9):855–62. doi: .
    1. Martin JA, Hamilton BE, Osterman MJ. Births in the United States, 2014. NCHS Data Brief. 2015;(216):1–8. .
    1. Meredith RM. Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders. Neurosci Biobehav Rev. 2015;50:180–8. doi: .
    1. Mueller CA, Eme J, Burggren WW, Roghair RD, Rundle SD. Challenges and opportunities in developmental integrative physiology. Comp Biochem Physiol A Mol Integr Physiol. 2015;184:113–24. doi: .
    1. Johnson S, Marlow N. Preterm birth and childhood psychiatric disorders. Pediatr Res. 2011;69(5 Pt 2):11R–8R. doi: .
    1. Montagna A, Nosarti C. Socio-Emotional Development Following Very Preterm Birth: Pathways to Psychopathology. Front Psychol. 2016;7 ARTN 80 doi:
    1. Kapellou O, Counsell SJ, Kennea N, Dyet L, Saeed N, Stark J, et al. Abnormal cortical development after premature birth shown by altered allometric scaling of brain growth. PLoS Med. 2006;3(8):e265 doi:
    1. Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J. Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics. 2009;124(2):717–28. Epub 2009/08/05. doi: .
    1. Delobel-Ayoub M, Arnaud C, White-Koning M, Casper C, Pierrat V, Garel M, et al. Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics. 2009;123(6):1485–92. Epub 2009/06/02. doi: .
    1. Treyvaud K, Ure A, Doyle LW, Lee KJ, Rogers CE, Kidokoro H, et al. Psychiatric outcomes at age seven for very preterm children: rates and predictors. J Child Psychol Psychiatry. 2013. Epub 2013/01/26. doi: .
    1. Ahlsson F, Kaijser M, Adami J, Lundgren M, Palme M. School performance after preterm birth. Epidemiology. 2015;26(1):106–11. doi: .
    1. de Jong M, Verhoeven M, van Baar AL. School outcome, cognitive functioning, and behaviour problems in moderate and late preterm children and adults: a review. Semin Fetal Neonatal Med. 2012;17(3):163–9. doi: .
    1. de Jong M, Verhoeven M, van Baar AL. Attention capacities of preterm and term born toddlers: A multi-method approach. Early Hum Dev. 2015;91(12):761–8. doi: .
    1. Downey LC, O'Shea TM, Allred EN, Kuban K, McElrath TF, Warner DD, et al. Antenatal and early postnatal antecedents of parent-reported attention problems at 2 years of age. J Pediatr. 2015;166(1):20–5. doi: .
    1. Elgen SK, Sommerfelt K, Leversen KT, Markestad T. Minor neurodevelopmental impairments are associated with increased occurrence of ADHD symptoms in children born extremely preterm. Eur Child Adolesc Psychiatry. 2015;24(4):463–70. doi: .
    1. Guy A, Seaton SE, Boyle EM, Draper ES, Field DJ, Manktelow BN, et al. Infants born late/moderately preterm are at increased risk for a positive autism screen at 2 years of age. J Pediatr. 2015;166(2):269–75 e3. doi: .
    1. Monnier M, Jaunin L, Bickle Graz M, Borradori Tolsa C, Huppi P, Sancho Rossignol A, et al. [Detection of executive function disorders with a standard neurodevelopmental follow-up of premature children]. Arch Pediatr. 2014;21(9):944–52. doi: .
    1. Andrews B, Lagatta J, Chu A, Plesha-Troyke S, Schreiber M, Lantos J, et al. The Non-impact of Gestational Age on Neuro-developmental Outcome for Ventilated Survivors Born at 23–28 Weeks Gestation. Acta Paediatr. 2012. Epub 2012/01/27. doi: .
    1. Conrad AL, Richman L, Lindgren S, Nopoulos P. Biological and environmental predictors of behavioral sequelae in children born preterm. Pediatrics. 2010;125(1):e83–9. Epub 2009/12/17. doi:
    1. Linsell L, Malouf R, Morris J, Kurinczuk JJ, Marlow N. Prognostic Factors for Poor Cognitive Development in Children Born Very Preterm or With Very Low Birth Weight: A Systematic Review. JAMA Pediatr. 2015;169(12):1162–72. doi: .
    1. Kraft AD, Aschner M, Cory-Slechta DA, Bilbo SD, Caudle WM, Makris SL. Unmasking silent neurotoxicity following developmental exposure to environmental toxicants. Neurotoxicol Teratol. 2016;55:38–44. doi: .
    1. Mundy WR, Padilla S, Breier JM, Crofton KM, Gilbert ME, Herr DW, et al. Expanding the test set: Chemicals with potential to disrupt mammalian brain development. Neurotoxicol Teratol. 2015;52(Pt A):25–35. doi: .
    1. Latini G, De Felice C, Del Vecchio A, Barducci A, Ferri M, Chiellini F. Di-(2-ethylhexyl)phthalate leakage and color changes in endotracheal tubes after application in high-risk newborns. Neonatology. 2009;95(4):317–23. Epub 2008/12/17. doi: .
    1. Latini G, Ferri M, Chiellini F. Materials degradation in PVC medical devices, DEHP leaching and neonatal outcomes. Curr Med Chem. 2010;17(26):2979–89. Epub 2010/09/23. .
    1. Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics. 2004;113(5):e429–34. Epub 2004/05/04. .
    1. Green R, Hauser R, Calafat AM, Weuve J, Schettler T, Ringer S, et al. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect. 2005;113(9):1222–5. Epub 2005/09/06. doi:
    1. Weuve J, Sanchez BN, Calafat AM, Schettler T, Green RA, Hu H, et al. Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites. Environ Health Perspect. 2006;114(9):1424–31. Epub 2006/09/13. doi:
    1. Department of Health and Human Services, Centers for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA2009.
    1. Calafat AM, Ye X, Silva MJ, Kuklenyik Z, Needham LL. Human exposure assessment to environmental chemicals using biomonitoring. Int J Androl. 2006;29(1):166–71; discussion 81–5. doi: .
    1. Ventrice P, Ventrice D, Russo E, De Sarro G. Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity. Environ Toxicol Pharmacol. 2013;36(1):88–96. doi: .
    1. Mallow EB, Fox MA. Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks. J Perinatol. 2014;34(12):892–7. doi: .
    1. Ejaredar M, Nyanza EC, Ten Eycke K, Dewey D. Phthalate exposure and childrens neurodevelopment: A systematic review. Environ Res. 2015;142:51–60. doi: .
    1. Engel SM, Miodovnik A, Canfield RL, Zhu C, Silva MJ, Calafat AM, et al. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect. 2010;118(4):565–71. doi:
    1. Kim Y, Ha EH, Kim EJ, Park H, Ha M, Kim JH, et al. Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children's Environmental Health (MOCEH) study. Environ Health Perspect. 2011;119(10):1495–500. doi:
    1. Lien YJ, Ku HY, Su PH, Chen SJ, Chen HY, Liao PC, et al. Prenatal exposure to phthalate esters and behavioral syndromes in children at 8 years of age: Taiwan Maternal and Infant Cohort Study. Environ Health Perspect. 2015;123(1):95–100. doi:
    1. Philippat C, Bennett DH, Krakowiak P, Rose M, Hwang HM, Hertz-Picciotto I. Phthalate concentrations in house dust in relation to autism spectrum disorder and developmental delay in the CHildhood Autism Risks from Genetics and the Environment (CHARGE) study. Environmental health: a global access science source. 2015;14:56 doi:
    1. Polanska K, Ligocka D, Sobala W, Hanke W. Phthalate exposure and child development: the Polish Mother and Child Cohort Study. Early Hum Dev. 2014;90(9):477–85. doi: .
    1. Tellez-Rojo MM, Cantoral A, Cantonwine DE, Schnaas L, Peterson K, Hu H, et al. Prenatal urinary phthalate metabolites levels and neurodevelopment in children at two and three years of age. Sci Total Environ. 2013;461–462:386–90. doi:
    1. Engel SM, Zhu C, Berkowitz GS, Calafat AM, Silva MJ, Miodovnik A, et al. Prenatal phthalate exposure and performance on the Neonatal Behavioral Assessment Scale in a multiethnic birth cohort. Neurotoxicology. 2009;30(4):522–8. doi:
    1. Yolton K, Xu Y, Strauss D, Altaye M, Calafat AM, Khoury J. Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neurotoxicol Teratol. 2011;33(5):558–66. doi:
    1. Park S, Kim BN, Cho SC, Kim Y, Kim JW, Lee JY, et al. Association between urine phthalate levels and poor attentional performance in children with attention-deficit hyperactivity disorder with evidence of dopamine gene-phthalate interaction. Int J Environ Res Public Health. 2014;11(7):6743–56. doi:
    1. Testa C, Nuti F, Hayek J, De Felice C, Chelli M, Rovero P, et al. Di-(2-ethylhexyl) phthalate and autism spectrum disorders. ASN Neuro. 2012;4(4):223–9. doi:
    1. Cho SC, Bhang SY, Hong YC, Shin MS, Kim BN, Kim JW, et al. Relationship between environmental phthalate exposure and the intelligence of school-age children. Environ Health Perspect. 2010;118(7):1027–32. doi:
    1. Factor-Litvak P, Insel B, Calafat AM, Liu X, Perera F, Rauh VA, et al. Persistent Associations between Maternal Prenatal Exposure to Phthalates on Child IQ at Age 7 Years. PLoS One. 2014;9(12):e114003 doi:
    1. Stroustrup A, Teitelbaum SL, Aschner JL. The Value of Preterm Infant Environmental Health Cohorts: The Canary in the Coal Mine. JAMA Pediatr. 2017; 171(12):1139–1140. doi: .
    1. Silva MJ, Slakman AR, Reidy JA, Preau JL Jr., Herbert AR, Samandar E, et al. Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;805(1):161–7. doi: .
    1. Silva MJ, Samandar E, Preau JL Jr., Reidy JA, Needham LL, Calafat AM. Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;860(1):106–12. doi: .
    1. Boukydis CF, Bigsby R, Lester BM. Clinical use of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics. 2004;113(3 Pt 2):679–89. Epub 2004/03/03. .
    1. Lester BM, Tronick EZ. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics. 2004;113(3 Pt 2):634–40. Epub 2004/03/03. .
    1. Lester BM, Tronick EZ, Brazelton TB. The Neonatal Intensive Care Unit Network Neurobehavioral Scale procedures. Pediatrics. 2004;113(3 Pt 2):641–67. Epub 2004/03/03. .
    1. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, et al. Summary statistics of neonatal intensive care unit network neurobehavioral scale scores from the maternal lifestyle study: a quasinormative sample. Pediatrics. 2004;113(3 Pt 2):668–75. Epub 2004/03/03. .
    1. Tronick E, Lester BM. Grandchild of the NBAS: the NICU network neurobehavioral scale (NNNS): a review of the research using the NNNS. J Child Adolesc Psychiatr Nurs. 2013;26(3):193–203. doi:
    1. Tronick EZ, Olson K, Rosenberg R, Bohne L, Lu J, Lester BM. Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics. 2004;113(3 Pt 2):676–8. Epub 2004/03/03. .
    1. Liu J, Bann C, Lester B, Tronick E, Das A, Lagasse L, et al. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics. 2010;125(1):e90–8. Epub 2009/12/09. doi:
    1. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics. 2002;110(6):1182–92. .
    1. Montirosso R, Del Prete A, Bellu R, Tronick E, Borgatti R, Neonatal Adequate Care for Quality of Life Study G. Level of NICU quality of developmental care and neurobehavioral performance in very preterm infants. Pediatrics. 2012;129(5):e1129–37. doi:
    1. Smith JR, McGrath J, Brotto M, Inder T. A randomized-controlled trial pilot study examining the neurodevelopmental effects of a 5-week M Technique intervention on very preterm infants. Adv Neonatal Care. 2014;14(3):187–200. doi: .
    1. Textor J. [Our moral ancestors: determining adjustment sets in causal diagrams with ease]. Gesundheitswesen. 2011;73(12):897–900. doi: .
    1. Textor J, Hardt J, Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22(5):745 doi: .
    1. Parry G, Tucker J, Tarnow-Mordi W, Group UKNSSC. CRIB II: an update of the clinical risk index for babies score. Lancet. 2003;361(9371):1789–91. doi: .
    1. Teitelbaum SL, Mervish N, Moshier EL, Vangeepuram N, Galvez MP, Calafat AM, et al. Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res. 2012;112:186–93. doi:
    1. Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, et al. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect. 2008;116(8):1092–7. doi:
    1. Carrico C, Gennings C, Wheeler D, Factor-Litvak P. Characterization of a weighted quartile sum regression for highly correlated data in a risk analysis setting. J Agric Biol Environ Stat. 2014;in press.
    1. Gennings C, Carrico C, Factor-Litvak P, Krigbaum N, Cirillo PM, Cohn BA. A cohort study evaluation of maternal PCB exposure related to time to pregnancy in daughters. Environmental health: a global access science source. 2013;12(1):66 doi:
    1. Van Vliet ED, Reitano EM, Chhabra JS, Bergen GP, Whyatt RM. A review of alternatives to di (2-ethylhexyl) phthalate-containing medical devices in the neonatal intensive care unit. J Perinatol. 2011;31(8):551–60. Epub 2011/02/12. doi: .
    1. Lester BM, Tronick EZ. NICU Network Neurobehavioral Scale Manual. Baltimore, MD: Paul H. Brookes Publishing Co., Inc.; 2004.
    1. Calafat AM, Longnecker MP, Koch HM, Swan SH, Hauser R, Goldman LR, et al. Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology. Environ Health Perspect. 2015;123(7):A166–8. doi:
    1. Frederiksen H, Kuiri-Hanninen T, Main KM, Dunkel L, Sankilampi U. A longitudinal study of urinary phthalate excretion in 58 full-term and 67 preterm infants from birth through 14 months. Environ Health Perspect. 2014;122(9):998–1005. doi:
    1. Whyatt RM, Liu X, Rauh VA, Calafat AM, Just AC, Hoepner L, et al. Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ Health Perspect. 2012;120(2):290–5. doi:
    1. Sampson J, de Korte D. DEHP-plasticised PVC: relevance to blood services. Transfus Med. 2011;21(2):73–83. doi: .
    1. Martinez-Arguelles DB, Papadopoulos V. Prenatal phthalate exposure: epigenetic changes leading to lifelong impact on steroid formation. Andrology. 2016;4(4):573–84. doi: .
    1. Skinner MK. Endocrine disruptors in 2015: Epigenetic transgenerational inheritance. Nat Rev Endocrinol. 2016;12(2):68–70. doi: .
    1. Wilson VS, Blystone CR, Hotchkiss AK, Rider CV, Gray LE Jr. Diverse mechanisms of anti-androgen action: impact on male rat reproductive tract development. Int J Androl. 2008;31(2):178–87. doi: .
    1. Lejeune F, Parra J, Berne-Audeoud F, Marcus L, Barisnikov K, Gentaz E, et al. Sound Interferes with the Early Tactile Manual Abilities of Preterm Infants. Sci Rep. 2016;6:23329 doi:
    1. Posner J, Cha J, Roy AK, Peterson BS, Bansal R, Gustafsson HC, et al. Alterations in amygdala-prefrontal circuits in infants exposed to prenatal maternal depression. Transl Psychiatry. 2016;6(11):e935 doi: .
    1. Glover V. Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv Neurobiol. 2015;10:269–83. doi: .
    1. Grizenko N, Fortier ME, Gaudreau-Simard M, Jolicoeur C, Joober R. The Effect of Maternal Stress during Pregnancy on IQ and ADHD Symptomatology. J Can Acad Child Adolesc Psychiatry. 2015;24(2):92–9.
    1. Scheinost D, Sinha R, Cross SN, Kwon SH, Sze G, Constable RT, et al. Does prenatal stress alter the developing connectome? Pediatr Res. 2016. doi: .
    1. Udagawa J, Hino K. Impact of Maternal Stress in Pregnancy on Brain Function of the Offspring. Nihon Eiseigaku Zasshi. 2016;71(3):188–94. doi: .
    1. Anderson WA, Castle L, Hird S, Jeffery J, Scotter MJ. A twenty-volunteer study using deuterium labelling to determine the kinetics and fractional excretion of primary and secondary urinary metabolites of di-2-ethylhexylphthalate and di-iso-nonylphthalate. Food Chem Toxicol. 2011;49(9):2022–9. doi: .
    1. Kessler W, Numtip W, Volkel W, Seckin E, Csanady GA, Putz C, et al. Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP. Toxicol Appl Pharmacol. 2012;264(2):284–91. doi: .
    1. Koch HM, Angerer J. Di-iso-nonylphthalate (DINP) metabolites in human urine after a single oral dose of deuterium-labelled DINP. Int J Hyg Environ Health. 2007;210(1):9–19. doi: .
    1. Koch HM, Bolt HM, Preuss R, Angerer J. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol. 2005;79(7):367–76. doi: .
    1. Lester BM, Andreozzi-Fontaine L, Tronick E, Bigsby R. Assessment and evaluation of the high risk neonate: the NICU Network Neurobehavioral Scale. J Vis Exp. 2014;(90). doi:
    1. Madlinger-Lewis L, Reynolds L, Zarem C, Crapnell T, Inder T, Pineda R. The effects of alternative positioning on preterm infants in the neonatal intensive care unit: a randomized clinical trial. Res Dev Disabil. 2014;35(2):490–7. doi:
    1. Donauer S, Chen A, Xu Y, Calafat AM, Sjodin A, Yolton K. Prenatal exposure to polybrominated diphenyl ethers and polyfluoroalkyl chemicals and infant neurobehavior. J Pediatr. 2015;166(3):736–42. doi:
    1. Yolton K, Xu Y, Sucharew H, Succop P, Altaye M, Popelar A, et al. Impact of low-level gestational exposure to organophosphate pesticides on neurobehavior in early infancy: a prospective study. Environmental health: a global access science source. 2013;12(1):79 doi:
    1. Bernard L, Decaudin B, Lecoeur M, Richard D, Bourdeaux D, Cueff R, et al. Analytical methods for the determination of DEHP plasticizer alternatives present in medical devices: a review. Talanta. 2014;129:39–54. doi: .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe